Results 201 to 210 of about 127,357 (301)

Orthostatic Myoclonus—Clinical and Electrophysiological Features in a Large Retrospective Cohort

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Orthostatic myoclonus is characterized by irregular, lower limb myoclonic bursts during stance and is a major cause of postural instability and falls. However, studies are limited, and little is known about its pathophysiology. Objectives We sought to define the clinical and electrophysiological features of orthostatic myoclonus in ...
Sai A. Nagaratnam, Niroshan Jeyakumar, Gobishan Jeyakumar, Florence Chang, Duncan Wilson, Paloma Becker, Hugo Morales‐Briceno, Neil Mahant, Victor S.C. Fung   +8 more
wiley   +1 more source

Relative importance of blood-based biomarkers for Alzheimer's disease-specific neurodegeneration and cognitive decline. [PDF]

J Prev Alzheimers Dis
Kim KY, Ham H, Yoon EJ, Kim E, Kim YK, Lee JY, Alzheimer’s Disease Neuroimaging Initiative.   +6 more
europepmc   +1 more source

Recent Advances in Exosome‐Based Nanodelivery Systems for Traumatic Brain Injury Treatment

Med Research, EarlyView.
An overview of functional modification, therapeutic effects, molecular composition, and delivery strategies for exosomes. ABSTRACT Traumatic brain injury (TBI) is a highly heterogeneous neurological condition with extremely high rates of mortality and disability.
Jue Zhu, Weiquan Liao, Ziqi Lian, Mengdan Zhang, Chenxing Wang, Xingjia Zhu, Lin Zhang, Jian Chen, Zhichao Lu, Peipei Gong   +9 more
wiley   +1 more source

Assessment of Brain-Specific and Neuroendocrine Biomarkers for Intracerebral Hemorrhage Diagnosis: A Prospective Cohort Study. [PDF]

Biomark Insights
Apiliogullari S, Elbayoumi E, Collier N, Cai G, Ocloo OK, Golpich M, Kobeissy F, Zhu J, Yadikar H, Ng S, Poon WS, Wang KK.   +11 more
europepmc   +1 more source

Association Between Plasma Phosphorylated Tau‐217 and Cognition in Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background Alzheimer's disease (AD) co‐pathology contributes to dementia in PD, but its role in earlier cognitive impairment remains uncertain. Objective To determine if p‐tau217, a biomarker of early AD, is associated with cognitive impairment in PD.
Trycia Kouchache, Tevy Chan, Sophie Sun, Lang Liu, Aline Delva, Ziv Gan‐Or, Pedro Rosa‐Neto, Jean‐François Gagnon, Alain Dagher, Ronald B. Postuma, Madeleine Sharp   +10 more
wiley   +1 more source

Varicose projection astrocytes: Conserved reactive cells in brain pathology. [PDF]

Sci Adv
Ciani C, Pistorio G, Giancola S, Mearelli M, Mongelli FE, Forouzeh D, Campos Soares L, Gonzalez Martin M, Lichtenstein ME, Mio L, Christou E, Hastings K, Nguyen Do AQ, Ramos-Gonzalez P, Matute C, Kuliesiute U, Dötterer SE, Luksys G, Rocka S, Neniskyte U, Anthony DC, Ayub M, Centelleghe C, Arevalo MA, Graïc JM, Petrelli F, Verkhratsky A, Iraci N, Cavaliere F, Muñoz-Ballester C, Salman MM, Ulloa Severino FP, Falcone C.   +32 more
europepmc   +1 more source

GFAP im Liquor [PDF]

, 2019
openaire   +1 more source

Mutations in GFAP Alter Early Lineage Commitment of Organoids

Glial fibrillary acidic protein (GFAP) is a type-3 intermediate filament protein mainly expressed in astrocytes in the central nervous system. Mutations in GFAP cause Alexander disease (AxD), a rare and fatal neurological disorder.
Regenerative Medicine and Stem Cells, Valihrach, Lukas, Brain, Pérez-Sala, Dolores, Li, Li, Shi, Yanhong, Kubista, Mikael, Ahlenius, Henrik, Goya-Iglesias, Nuria, TN groep Hol, Pasterkamp, R Jeroen, Chao, Jianfei, CMM Groep Burgering, Dykstra, Werner, Matusova, Zuzana, Translational Neuroscience, Abaffy, Pavel, Battaglia, Rachel A, Pekny, Milos, Hol, Elly M, Cancer   +20 more
core  

GFAP-Dependent Transcriptional Dynamics and Cellular Heterogeneity in Primary, Recurrent, and Grade III Gliomas. [PDF]

Cancer Inform
Hadizadeh M, Mousavi SZ, Ghasemi S.
europepmc   +1 more source

High‐Fat Diet Exacerbates Neuropathology in a Transgenic Mouse Model of Multiple System Atrophy

Movement Disorders, EarlyView.
Abstract Background Multiple system atrophy (MSA) is a rare and devastating neurodegenerative disorder. Accumulating clinical and preclinical evidence suggests that diabetes and insulin resistance may adversely influence MSA pathophysiology. Objective We investigated the potential association between diabetes, impaired glucose homeostasis, and MSA ...
Marie‐Laure Arotcarena, Anna Delamarre, Miguel Lopez‐Cuina, Hugo Martin, Elio Balpe, Xavier Fioramonti, Erwan Bezard, Wassilios G. Meissner   +7 more
wiley   +1 more source